<?xml version="1.0" encoding="UTF-8"?>
<p id="Par48">The standard anti-HIV drug therapy involves the combination of drugs from different classes that target at least two different steps of the HIV replication cycle
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. Since compound 
 <bold>#7</bold> acts on a step different from all known drugs it is an excellent candidate for combination anti-HIV therapy. In support, we demonstrate its capacity to synergize with several clinical anti-HIV drugs.
</p>
